R. Todd Stravitz

6.0k total citations · 2 hit papers
59 papers, 4.3k citations indexed

About

R. Todd Stravitz is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, R. Todd Stravitz has authored 59 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 31 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in R. Todd Stravitz's work include Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (22 papers) and Hepatitis C virus research (14 papers). R. Todd Stravitz is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (22 papers) and Hepatitis C virus research (14 papers). R. Todd Stravitz collaborates with scholars based in United States, China and Canada. R. Todd Stravitz's co-authors include William M. Lee, Richard K. Sterling, Arun J. Sanyal, Velimir A. Luketic, Phillip B. Hylemon, Mitchell L. Shiffman, Z.R. Vlahcevic, Melissa J. Contos, A. Scott Mills and Paul Dent and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

R. Todd Stravitz

59 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute liver failure

2019 572 citations R. Todd Stravitz, William M. Lee The Lancet profile →
Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure

2009 431 citations William M. Lee, Robert J. Fontana et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Todd Stravitz United States	36	2.2k	2.1k	1.4k	968	939	59	4.3k
Adrian Reuben United States	38	1.9k 0.8×	2.0k 0.9×	1.3k 0.9×	976 1.0×	793 0.8×	140	4.6k
Joan Caballería Spain	40	2.3k 1.0×	3.3k 1.5×	890 0.6×	483 0.5×	272 0.3×	95	5.4k
J Domergue France	32	1.0k 0.5×	899 0.4×	1.3k 1.0×	1.2k 1.2×	1.4k 1.5×	107	4.2k
Piotr Milkiewicz Poland	35	1.9k 0.8×	1.8k 0.8×	1.5k 1.1×	250 0.3×	750 0.8×	210	3.9k
Jean‐Michel Fabre France	35	1.1k 0.5×	899 0.4×	1.4k 1.0×	1.0k 1.1×	1.7k 1.8×	91	4.2k
Martin Wagner Austria	41	1.8k 0.8×	2.6k 1.2×	2.2k 1.6×	990 1.0×	3.3k 3.5×	81	6.2k
Satoru Kakizaki Japan	32	1.0k 0.5×	1.1k 0.5×	771 0.6×	537 0.6×	709 0.8×	189	3.4k
Gernot Zollner Austria	38	2.0k 0.9×	2.3k 1.1×	2.4k 1.8×	1.2k 1.2×	3.8k 4.1×	87	5.9k
Lars P. Bechmann Germany	28	1.1k 0.5×	1.9k 0.9×	624 0.5×	373 0.4×	270 0.3×	79	3.2k
Burton Combes United States	37	1.5k 0.7×	1.6k 0.7×	652 0.5×	703 0.7×	755 0.8×	114	4.1k

Countries citing papers authored by R. Todd Stravitz

Since Specialization

Citations

This map shows the geographic impact of R. Todd Stravitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Todd Stravitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Todd Stravitz more than expected).

Fields of papers citing papers by R. Todd Stravitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Todd Stravitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Todd Stravitz. The network helps show where R. Todd Stravitz may publish in the future.

Co-authorship network of co-authors of R. Todd Stravitz

This figure shows the co-authorship network connecting the top 25 collaborators of R. Todd Stravitz. A scholar is included among the top collaborators of R. Todd Stravitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Todd Stravitz. R. Todd Stravitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fagan, Andrew, Edith Gavis, Brian Davis, et al.. (2022). A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. Journal of Hepatology. 78(2). 312–321. 39 indexed citations

Stravitz, R. Todd & William M. Lee. (2019). Acute liver failure. The Lancet. 394(10201). 869–881. 572 indexed citations breakdown →

Sterling, Richard K., Carolyn Driscoll, Scott Matherly, et al.. (2018). Treatment of HCV in the Department of Corrections in the Era of Oral Medications. Journal of Correctional Health Care. 24(2). 127–136. 30 indexed citations

Siddiqui, M. Shadab & R. Todd Stravitz. (2014). Intensive Care Unit Management of Patients with Liver Failure. Clinics in Liver Disease. 18(4). 957–978. 20 indexed citations

Verna, Elizabeth C., James R. Burton, Jacqueline G. O’Leary, et al.. (2013). 23 A MULTICENTER STUDY OF PROTEASE INHIBITOR-TRIPLE THERAPY IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS: REPORT FROM THE CRUSH-C GROUP. Journal of Hepatology. 58. S10–S11. 18 indexed citations

Matherly, Scott, Imran Farooq, R. Todd Stravitz, et al.. (2012). Modified‐orientation log to assess hepatic encephalopathy. Alimentary Pharmacology & Therapeutics. 35(8). 913–920. 19 indexed citations

Stravitz, R. Todd, Jay H. Lefkowitch, Robert J. Fontana, et al.. (2010). Autoimmune acute liver failure: Proposed clinical and histological criteria. Hepatology. 53(2). 517–526. 191 indexed citations

Stravitz, R. Todd, et al.. (2009). Peritoneal sarcoidosis: a unique cause of ascites and intractable hiccups.. PubMed. 5(12). 859–61. 11 indexed citations

Smith, Jenny O., Richard K. Sterling, A. Scott Mills, et al.. (2008). Herpes Simplex Virus Colitis in a Patient with Crohnʼs Disease and Hepatitis B and D Cirrhosis. The American Journal of Gastroenterology. 103. S336–S336. 7 indexed citations

10.

Yılmaz, Nevin, Mitchell L. Shiffman, R. Todd Stravitz, et al.. (2007). Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years. Liver International. 28(1). 72–78. 17 indexed citations

11.

Shiffman, Mitchell L., Angie Price, Richard K. Sterling, et al.. (2007). Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha†. Hepatology. 46(2). 371–379. 144 indexed citations

12.

Stravitz, R. Todd, Richard K. Sterling, Velimir A. Luketic, et al.. (2005). Antibody-Mediated Pure Red Cell Aplasia Due to Epoetin Alfa During Antiviral Therapy of Chronic Hepatitis C. The American Journal of Gastroenterology. 100(6). 1415–1419. 37 indexed citations

13.

Sterling, Richard K., R. Todd Stravitz, Velimir A. Luketic, et al.. (2004). A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clinical Gastroenterology and Hepatology. 2(6). 469–473. 68 indexed citations

14.

Chang, Seong‐Hwan, et al.. (2004). Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV. Liver Transplantation. 10(11). 1432–1435. 2 indexed citations

15.

Shakil, A. Obaid, et al.. (2003). 116 Serum phosphate as a predictor of clinical outcome in acetaminophen-induced acute liver failure. Hepatology. 38. 212–212. 3 indexed citations

16.

Cotterell, Adrian, Robert A. Fisher, Anne L. King, et al.. (2002). Calcineurin inhibitor‐induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent. Clinical Transplantation. 16(s7). 49–51. 42 indexed citations

17.

Gupta, Seema, R. Todd Stravitz, Paul Dent, & Phillip B. Hylemon. (2001). Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway. Journal of Biological Chemistry. 276(19). 15816–15822. 281 indexed citations

18.

Zr, Vlahcevic, et al.. (1997). Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology. 113(6). 1949–1957. 86 indexed citations

19.

Stravitz, R. Todd, et al.. (1996). Regulation of sterol 27-hydroxylase and an alternative pathway of bile acid biosynthesis in primary cultures of rat hepatocytes. The Journal of Steroid Biochemistry and Molecular Biology. 57(5-6). 337–347. 64 indexed citations

20.

Hylemon, P B, R. Todd Stravitz, & Z.R. Vlahcevic. (1994). Molecular genetics and regulation of bile acid biosynthesis.. PubMed. 12. 99–120. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact